Loading…
Based on limited metadata with no full letter text available, this warning letter was issued to Medtronic Inc.'s Cardiac Rhythm and Heart Failure division in July 2018, indicating regulatory concerns with their cardiac or heart failure-related medical devices or products. While the specific nature of the violations cannot be determined from the available metadata, the warning suggests FDA compliance issues within the cardiac device category under an unspecified issuing office. Without access to the complete letter text, the precise regulatory violations and their scope remain undetermined.